Royal College of Surgeons in Ireland
Browse
Reply to Chan. identification of alpha-1 antitrypsin-deficient subjects with normal spirometry who may benefit from alpha-1 antitrypsin replacement.pdf (554.65 kB)

Reply to Chan: Identification of alpha-1 antitrypsin-deficient subjects with normal spirometry who may benefit from alpha-1 antitrypsin replacement

Download (554.65 kB)
journal contribution
posted on 2024-05-09, 13:42 authored by Daniel Fraughen, Auyon J Ghosh, Tomas CarrollTomas Carroll, Noel G McElvaneyNoel G McElvaney

We thank Dr. Chan for his insightful comments and expert analysis of our paper, which raise a number of important questions.In our cohort of 52 individuals with a bronchodilator response (BDR), 40 individuals had follow-up spirometry. There was a mean (6SD) of 7.9 (69.1) subsequent pulmonary function tests performed per person and a mean of 3.4 (62.7) further BDRs performed per person. We repeated the linear mixed model that was used to estimate yearly FEV1 change and included the BDR at baseline as a covariate. BDR was not significantly associated with yearly FEV1 change (22.7 ml/yr; 95% confidence interval:225.2, 19.8;P= 0.82)  

History

Comments

The original article is available at https://www.atsjournals.org/

Published Citation

Fraughen DD, Ghosh AJ, Carroll TP, McElvaney NG. Reply to Chan: Identification of alpha-1 antitrypsin-deficient subjects with normal spirometry who may benefit from alpha-1 antitrypsin replacement. Am J Respir Crit Care Med. 2024;209(8):1034-1035.

Publication Date

15 April 2024

PubMed ID

38237155

Department/Unit

  • Beaumont Hospital
  • Medicine

Publisher

American Thoracic Society

Version

  • Published Version (Version of Record)

Usage metrics

    Royal College of Surgeons in Ireland

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC